(Total Views: 683)
Posted On: 12/28/2020 12:09:22 AM
Post# of 153907
“So seems for sure that no one will be dosed on open label extension until Tuesday at the earliest.”
Seems unlikely the FDA will approve the open label extension that quickly. The protocol should be nearly identical, although CYDY should modify the trial protocol to allow patients to receive more than 2 doses of leronlimab.
Seems unlikely the FDA will approve the open label extension that quickly. The protocol should be nearly identical, although CYDY should modify the trial protocol to allow patients to receive more than 2 doses of leronlimab.
(1)
(0)
